Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver June 21-24 2023 Back

Results of a Phase 1b, Open-label, Multicenter Study of Selgantolimod (GS-9688) in Special Populations of Patients With Chronic Hepatitis B       Results of a Phase 1b, Open-label, Multicenter Study of Selgantolimod (GS-9688) in Special Populations of Patients With Chronic Hepatitis B